Armata Pharmaceuticals, Inc. has reported positive outcomes from its Phase 2a diSArm study, evaluating the bacteriophage cocktail AP-SA02 as a potential treatment for complicated Staphylococcus aureus...
A recent survey conducted by MedCity News and commissioned by Smarter Technologies highlights a significant interest among medical billing professionals in the potential of artificial intelligence...
In a strategic move amid changing market dynamics, Bambu Ventures has finalized the acquisition of telemedicine company Lemonaid Health for just $10 million. This purchase comes...
A 16-year-old girl, recently discharged from a Chicago hospital after battling Stage 4 cancer, is advocating for her father’s release following his detention by federal immigration...
PawDoc Surgery + Dental Center has officially opened its doors in Katy, Texas, as of October 13, 2023. The facility specializes in surgical and dental care...
Neuphoria Therapeutics has announced the discontinuation of its social anxiety drug following a failed Phase 3 clinical trial. This decision comes as the company reassesses its...
Pollen-Food Allergy Syndrome (PFAS) affects a significant number of individuals with pollen allergies, yet it remains under-recognized. Research indicates that up to 70% of those with...
